BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4699017)

  • 1. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B; Olander R
    Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hyperuricemia with allopurinol].
    Hood B; Olander R; Sjöberg KH; Orndahl G
    Lakartidningen; 1968 Feb; 65(6):574-82. PubMed ID: 5723559
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 6. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allopurinol].
    Scott JT
    Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893
    [No Abstract]   [Full Text] [Related]  

  • 8. [Allopurinol: its clinical use].
    Zucchelli P; Sasdelli M; Fusaroli M
    G Clin Med; 1968 Oct; 49(10):1014-37. PubMed ID: 5735670
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allopurinol in the treatment of gout].
    Klein G; Griendl W; Kalb R
    Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Milurit on decreasing hyperuricaemia in hypertensive patients.
    Réthyly E; Pálfy A
    Ther Hung; 1974; 22(4):183-6. PubMed ID: 4465964
    [No Abstract]   [Full Text] [Related]  

  • 15. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allopurinol treatment of gout with special reference to patients with gouty nephropathy].
    Chodorowski Z; Muszkowska-Penson J; Stolarczyk J
    Wiad Lek; 1974 Apr; 27(8):705-10. PubMed ID: 4826801
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Allopurinol in the treatment of gout: initial results].
    Serre H; Simon L; Claustre J
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.